13D/13G Filings - Kymera Therapeutics Inc. (KYMR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-04
4:12 pm
Purchase
2021-12-3113GKymera Therapeutics, Inc.
KYMR
BlackRock Inc.
BLK
3,397,540
6.600%
3,397,540increase
(New Position)
Filing
History
2022-02-04
09:27 am
Purchase
2021-12-3113GKymera Therapeutics, Inc.
KYMR
Wellington Management Group LLP2,694,814
5.240%
2,694,814increase
(New Position)
Filing
History
2022-01-31
5:07 pm
Purchase
2022-01-2713DKymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P3,586,658
7.000%
955,996increase
(+36.34%)
Filing
History
2021-02-16
5:27 pm
Purchase
2020-12-3113GKymera Therapeutics, Inc.
KYMR
Atlas Venture Fund X L.P.7,948,982
17.900%
7,948,982increase
(New Position)
Filing
History
2021-02-16
4:10 pm
Purchase
2020-12-3113GKymera Therapeutics, Inc.
KYMR
Redmile Group, LLC2,720,489
6.100%
2,720,489increase
(New Position)
Filing
History
2021-02-08
10:27 am
Purchase
2021-02-0513GKymera Therapeutics, Inc.
KYMR
FMR LLC2,442,060
5.492%
2,442,060increase
(New Position)
Filing
History
2020-09-03
4:12 pm
Purchase
2020-08-2513DKymera Therapeutics, Inc.
KYMR
VERTEX PHARMACEUTICALS INC
VRTX
3,151,121
7.100%
3,151,121increase
(New Position)
Filing
History
2020-08-25
5:27 pm
Purchase
2020-08-2113DKymera Therapeutics, Inc.
KYMR
BIOTECHNOLOGY VALUE FUND L P2,630,662
5.900%
2,630,662increase
(New Position)
Filing
History
Goto Prev, 0, 1, 2